Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

infiltrating bladder urothelial carcinoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

infiltrating bladder urothelial carcinoma

MONDO:0003890

Also known as:infiltrating transitional cell carcinoma of the urinary bladderinvasive bladder transitional cell carcinomainvasive bladder urothelial carcinoma

Find Clinical TrialsTrials

Overview

An invasive transitional cell carcinoma that arises from the urinary bladder urothelium.

Clinical Trials32 registered · 12 recruiting

Diagnosis

Biomarker and diagnostic research for infiltrating bladder urothelial carcinoma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

32 clinical trials registered, 12 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE4, 2 PHASE3, 12 PHASE2. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05987241](https://clinicaltrials.gov/study/NCT05987241)

Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 11:36 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 32 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Laboratory research	26	36%
Testing and diagnosis research	17	23%
Disease patterns and progression	9	12%
Research summaries	7	10%
Patient case studies	6	8%
Clinical study results	4	5%
Other research	2	3%
New treatment approaches	2	3%

infiltrating bladder urothelial carcinoma

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications